Group B Streptococcal Infection Clinical Trial
Official title:
A Placebo Controlled Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without Human Immunodeficiency Virus (HIV) Infection and Their Infants
A placebo controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants
This Phase 2, randomised, placebo controlled, double blinded study will be the first evaluation of the investigational GBS6 in HIV-infected pregnant women. This study will enroll pregnant women with and without HIV to receive GBS6 or Placebo in order to provide an expanded safety and immunogenicity data set (for both pregnant women and their infants) and to support progression of the development of this vaccine. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02142933 -
Simplified GBS Screening and Prevalence of ESBL in Pregnant Women
|
N/A | |
Completed |
NCT04596878 -
Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV
|
Phase 2 | |
Withdrawn |
NCT04116645 -
Time Frame for GBS Screening
|
||
Terminated |
NCT02814318 -
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
|
||
Withdrawn |
NCT04227730 -
MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY
|
||
Completed |
NCT05154578 -
Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women
|
Phase 2 | |
Completed |
NCT02528981 -
Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT01577108 -
Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women
|
Phase 2 |